- Home
- FDUS vs NVCT Comparison
FDUS vs NVCT Comparison
Compare FDUS & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FDUS | NVCT |
|---|---|---|
| Founded | 2011 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 719.6M | 721.2M |
| IPO Year | 2011 | 2021 |
Fundamental Metrics
Financial Performance| Metric | FDUS | NVCT |
|---|---|---|
| Price | $19.07 | $18.39 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $21.00 | $10.00 |
| AVG Volume (30 Days) | ★ 317.8K | 276.8K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | ★ 11.49% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.65 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $9.39 | N/A |
| Revenue Next Year | $8.79 | N/A |
| P/E Ratio | $29.14 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.87 | $5.55 |
| 52 Week High | $22.09 | $29.28 |
Technical Indicators
Market Signals| Indicator | FDUS | NVCT |
|---|---|---|
| Relative Strength Index (RSI) | 57.68 | 55.77 |
| Support Level | $18.65 | $6.93 |
| Resistance Level | $19.36 | N/A |
| Average True Range (ATR) | 0.37 | 2.55 |
| MACD | 0.07 | 1.19 |
| Stochastic Oscillator | 92.97 | 44.96 |
Price Performance
Historical ComparisonAbout FDUS Fidus Investment Corporation
Fidus Investment Corp is an externally managed, closed-end, non-diversified management investment company that has elected to be treated as a business development company. The company provides customized debt and equity financing solutions to lower middle-market companies. Its investment objective is to provide attractive risk-adjusted returns by generating both current income from debt investments and capital appreciation from equity related investments. The company's portfolio of investment is comprised of securities of companies from different industries such as, Information Technology Services, Business Services, Healthcare Products among others.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.